HomeDMYD-B • STO
Diamyd Medical AB
krĀ 10.30
Jun 12, 6:00:00 PM GMT+2 · SEK · STO · Disclaimer
StockSE listed security
Previous close
krĀ 10.18
Day range
krĀ 9.91 - krĀ 10.30
Year range
krĀ 7.50 - krĀ 25.00
Market cap
1.38B SEK
Avg Volume
560.95K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK)Feb 2025Y/Y change
Revenue
86.00K230.77%
Operating expense
44.69M59.86%
Net income
-44.87M-53.39%
Net profit margin
-52.17K53.63%
Earnings per share
——
EBITDA
-44.01M-60.78%
Effective tax rate
——
Total assets
Total liabilities
(SEK)Feb 2025Y/Y change
Cash and short-term investments
103.75M-24.35%
Total assets
180.88M-20.13%
Total liabilities
69.35M53.23%
Total equity
111.53M—
Shares outstanding
104.09M—
Price to book
9.51—
Return on assets
-56.58%—
Return on capital
-85.35%—
Net change in cash
(SEK)Feb 2025Y/Y change
Net income
-44.87M-53.39%
Cash from operations
-48.41M-36.64%
Cash from investing
-458.00K86.82%
Cash from financing
-635.00K-203.83%
Net change in cash
-49.13M-24.15%
Free cash flow
-32.72M-9.70%
About
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products. The company is headquartered in Stockholm, and maintains a manufacturing facility in UmeƄ. Wikipedia
Founded
1984
Website
Employees
30
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided ā€œas isā€ for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu